Immunotherapy Based on Natural Killer Cells May Soon Begin Clinical Studies – Immuno-Oncology News
Immuno-Oncology News |
Immunotherapy Based on Natural Killer Cells May Soon Begin Clinical Studies
Immuno-Oncology News Cyto-Sen Therapeutics, a Florida-based startup, is moving to bring a natural killer cell-based immunotherapy into clinical trials by late 2017. During the past decade, treatment approaches based on immunotherapy have attracted exceptional attention … |
